EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparison of trimethoprim-sulfamethoxazole versus minocycline monotherapy for treatment of Stenotrophomonas maltophilia pneumonia

Emily T Graves, Lynn Wardlow iD, Stella Ogake, Jose A Bazan, Kelci Coe iD, Kaitlyn Kuntz, Jessica L Elefritz iD

Journal of Antimicrobial Chemotherapy · 2025

DOI: 10.1093/jac/dkaf024 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Emily T Graves und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Ohio State University Wexner Medical Center, 410 W 10th Ave, Columbus, OH 43210, USA. Hauptthemen laut MEDLINE: Stenotrophomonas maltophilia, Trimethoprim, Sulfamethoxazole Drug Combination, Anti-Bacterial Agents, Gram-Negative Bacterial Infections. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To compare the rate of clinical cure and adverse effects in patients receiving definitive treatment with trimethoprim-sulfamethoxazole versus minocycline monotherapy for Stenotrophomonas maltophilia pneumonia.

Methods

A single-centre, retrospective cohort study of patients with S. maltophilia pneumonia admitted 1 March 2018—30 September 2023 was conducted comparing treatment with trimethoprim-sulfamethoxazole versus minocycline monotherapy. The primary outcome was the rate of clinical cure, defined as meeting two of the three prespecified criteria for a period of 48 hours while on definitive therapy: normalization of white blood cell count, absence of fever and hypothermia and decreased oxygen support. Secondary outcomes evaluated included time to clinical cure, infection-related and in-hospital mortality, pneumonia recurrence and incidence of adverse effects, which was a composite of acute kidney injury (AKI), hyperkalaemia and thrombocytopenia.

Results

Of 93 patients included, 48 received trimethoprim-sulfamethoxazole and 45 received minocycline. There was no difference in the primary outcome of clinical cure between the trimethoprim-sulfamethoxazole and minocycline groups (72.9% versus 66.7%, P = 0.51). S. maltophilia pneumonia recurrence was more common in the minocycline group compared to the trimethoprim-sulfamethoxazole group (35.6% versus 10.4%, P = 0.006). In-hospital mortality was higher in the trimethoprim-sulfamethoxazole group although there was no difference in infection-related in-hospital mortality (6.3% versus 2.3%, P = 0.62). The incidence of AKI, hyperkalaemia and thrombocytopenia did not differ between groups.

Conclusion

There was no difference in clinical cure rate for S. maltophilia pneumonia treatment between trimethoprim-sulfamethoxazole and minocycline monotherapy although higher rates of recurrent pneumonia were observed in patients treated with minocycline. Rates of adverse effects were similar between groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stenotrophomonas maltophiliaTrimethoprim, Sulfamethoxazole Drug CombinationAnti-Bacterial AgentsGram-Negative Bacterial InfectionsMinocyclinePneumonia, BacterialHumansMaleRetrospective StudiesFemaleAgedMiddle AgedTreatment OutcomeAged, 80 and overAdult

Substanzen

Trimethoprim, Sulfamethoxazole Drug CombinationAnti-Bacterial AgentsMinocycline

Autor:innen und Institutionen

  • Department of Pharmacy, The Ohio State University Wexner Medical Center, 410 W 10th Ave, Columbus, OH 43210, USA.
  • Division of Pulmonary Diseases, Critical Care Medicine, and Sleep, The Ohio State University College of Medicine, 370 W 9th Ave, Columbus, OH 43210, USA.
  • Division of Infectious Diseases, The Ohio State University College of Medicine, 370 W 9th Ave, Columbus, OH 43210, USA.
  • Division of Infectious Diseases, The Ohio State University College of Medicine Address: 370 W 9th Ave, Columbus, OH 43210, USA.
  • The Ohio State University, College of Pharmacy, 500 W 12th Ave, Columbus, OH 43210, USA.

ORCID-Profile: Lynn Wardlow, Kelci Coe, Jessica L Elefritz

Zitieren

APA

Graves, E. T., Wardlow, L., Ogake, S., Bazan, J. A., Coe, K., Kuntz, K., & Elefritz, J. L. (2025). Comparison of trimethoprim-sulfamethoxazole versus minocycline monotherapy for treatment of Stenotrophomonas maltophilia pneumonia. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf024

Vancouver

Graves ET, Wardlow L, Ogake S, Bazan JA, Coe K, Kuntz K, et al. Comparison of trimethoprim-sulfamethoxazole versus minocycline monotherapy for treatment of Stenotrophomonas maltophilia pneumonia. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf024

BibTeX
@article{Graves2025,
  author = {Graves, Emily T and Wardlow, Lynn and Ogake, Stella and Bazan, Jose A and Coe, Kelci and Kuntz, Kaitlyn and Elefritz, Jessica L},
  title = {Comparison of trimethoprim-sulfamethoxazole versus minocycline monotherapy for treatment of Stenotrophomonas maltophilia pneumonia},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  doi = {10.1093/jac/dkaf024}
}
Kostenlos starten →